Apg Asset Management N.V. Novo Cure LTD Transaction History

Apg Asset Management N.V.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$11.13 - $15.78 $46,746 - $66,276	-4,200 Reduced 19.13%	17,750 $265,000
Q3 2023 Nov 14, 2023	SELL	$16.15 - $42.35 $993,224 - $2.6 Million	-61,500 Reduced 73.7%	21,950 $354,000
Q1 2023 May 12, 2023	SELL	$56.44 - $118.81 $792,699 - $1.67 Million	-14,045 Reduced 14.41%	83,450 $5.02 Million
Q4 2022 Feb 14, 2023	BUY	$63.98 - $85.37 $6.24 Million - $8.32 Million	97,495 New	97,495 $7.15 Million

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.16B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Apg Asset Management N.V., based on Form 13F filings with the SEC.

Stay updated on Apg Asset Management N.V. with notifications on news.